Literature DB >> 11325793

Mutation screening of the muscarinic M(2) and M(3) receptor genes in normal and asthmatic subjects.

A G Fenech1, M J Ebejer, A E Felice, R Ellul-Micallef, I P Hall.   

Abstract

1. Muscarinic receptors are important in the development of airway hyperresponsiveness, and dysfunction of these receptors has been suggested to be present in asthma. 2. The human muscarinic M(2) and M(3) receptor genes were screened for polymorphic variation using single-stranded conformation polymorphism (SSCP) analysis, complemented by direct fluorescent sequencing. Forty-six random DNA samples and 46 respiratory physician diagnosed asthmatic samples were used as a template for analysis. 3. Within the muscarinic M(2) receptor gene, we identified two degenerate single base substitutions (1197T-->C, Thr-->Thr and 976A-->C, Arg-->Arg) in one random and one asthmatic sample respectively. Analysis of the 3' UTR region revealed an additional 'A' at bp 1793 (c.f. ATG). This was present in all of 49 samples analysed by sequencing or BsmI digest, suggesting that the published sequence (GenBank Accession NO: M16404) is incorrect. A common 3' UTR polymorphism (T-->A) was found at bp 1696 (c.f. ATG) (allelic frequency=65%, n=60), but this does not alter transcription factor recognition sites. 4. We were unable to identify any polymorphic variation within the muscarinic M(3) coding region or the flanking regions investigated, using the methods described. 5. The coding regions for the human muscarinic M(2) and M(3) receptor genes are both highly conserved. These data suggest that polymorphic variation within these coding sequences is unlikely to account for inter-individual variability in response to methacholine or anticholinergic therapy. The potential functional significance of the muscarinic M(2) receptor 3' UTR polymorphism (bp 1696) remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11325793      PMCID: PMC1572756          DOI: 10.1038/sj.bjp.0704039

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

Review 1.  Modulation of neurotransmission in airways.

Authors:  P J Barnes
Journal:  Physiol Rev       Date:  1992-07       Impact factor: 37.312

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  Formation of inositol polyphosphates in airway smooth muscle after muscarinic receptor stimulation.

Authors:  E R Chilvers; I H Batty; P J Barnes; S R Nahorski
Journal:  J Pharmacol Exp Ther       Date:  1990-02       Impact factor: 4.030

4.  Identification of a family of muscarinic acetylcholine receptor genes.

Authors:  T I Bonner; N J Buckley; A C Young; M R Brann
Journal:  Science       Date:  1987-07-31       Impact factor: 47.728

5.  Airways responses to ipratropium bromide do not vary with time in asthmatic subjects. Studies of interindividual and intraindividual variation of bronchodilatation and protection against histamine-induced bronchoconstriction.

Authors:  E Ihre; K Larsson
Journal:  Chest       Date:  1990-01       Impact factor: 9.410

6.  Parainfluenza virus type 1 reduces the affinity of agonists for muscarinic receptors in guinea-pig lung and heart.

Authors:  A D Fryer; E E el-Fakahany; D B Jacoby
Journal:  Eur J Pharmacol       Date:  1990-05-31       Impact factor: 4.432

7.  A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects.

Authors:  P A Minette; J W Lammers; C M Dixon; M T McCusker; P J Barnes
Journal:  J Appl Physiol (1985)       Date:  1989-12

8.  Autoradiographic visualization of muscarinic receptor subtypes in human and guinea pig lung.

Authors:  J C Mak; P J Barnes
Journal:  Am Rev Respir Dis       Date:  1990-06

9.  Muscarinic receptor subtypes in human and guinea pig lung.

Authors:  J C Mak; P J Barnes
Journal:  Eur J Pharmacol       Date:  1989-05-19       Impact factor: 4.432

10.  Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea pig airways.

Authors:  P A Minette; P J Barnes
Journal:  J Appl Physiol (1985)       Date:  1988-06
View more
  4 in total

1.  CHRM2 but not CHRM1 or CHRM3 polymorphisms are associated with asthma susceptibility in Mexican patients.

Authors:  Silvia Jiménez-Morales; Juan Luis Jiménez-Ruíz; Blanca Estela Del Río-Navarro; Efraín Navarro-Olivos; Guillermo Escamilla-Guerrero; Ram Savan; Michael Dean; Lorena Orozco
Journal:  Mol Biol Rep       Date:  2014-01-16       Impact factor: 2.316

Review 2.  Pharmacogenetic approaches in the treatment of asthma.

Authors:  Ian Sayers; Ian P Hall
Journal:  Curr Allergy Asthma Rep       Date:  2005-03       Impact factor: 4.919

3.  Pharmacogenomics of pediatric asthma.

Authors:  Sarika Gupta; Shally Awasthi
Journal:  Indian J Hum Genet       Date:  2010-09

Review 4.  Pharmacogenetics, pharmacogenomics and airway disease.

Authors:  Ian P Hall
Journal:  Respir Res       Date:  2001-11-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.